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*TK MUDIAYI, * *M TSHIMANGA
Abstract
Objective: To identify  the m ain  causes o f  confirm ed m alaria  deaths and assess the validity  
an d  the  re le v an c e  o f  u se  o f  th e  M D IF  in  d e te rm in in g  a reas  fo r im p ro v em en t o f  care . 
Design: A cross sectional study.
Setting: U n ited  B u law ayo  H o sp ita ls , a te r tia ry  h o sp ita l in  Z im babw e.
Subjects: Patients w hose cause o f  death  w as m alaria  using M IDF.
Results: O f  470  confirm ed cases adm itted  in  U B H  during the study period, 53 (11.2% ) died 
an d  w ere  inc luded  in  the  study. M ost dea th s occu rred  in  the  over 15 years  age g roup
(88.6% ) w ith only 3 deaths each in  the o ther groups. A ll patients w ere referred  o r adm itted 
to  U B H  w ith  com plicated  and  severe m alaria; 39(74 % ) had  m ore than  one com plication 
such as CM  and acute renal failure (A RP). M ost patients cam e from  or had  visited  a rural 
area and d id  not im plem ent basic prophylactic and therapeutic m easures pu t in  p lace by  the 
N M C P such  as early  self-m edication . T hree p regnan t w om en aborted . G u idelines regard ing  
investigations and treatm ent w ere no t strictly  adhered to. D elay in  seeking treatm ent and in
referring w as generally  observed  at all levels o f  the health  system . C ases o f  m alaria  deaths 
w ere found in the city  in  people w ho had not travelled  to  rural area. The M D IF w as used  in 
one case only.
Conclusion: M a la ria  m o rta lity  acco u n ted  fo r 11 %  o f  c o n firm ed  cases. M ain  cau ses  o f
death  w ere CM  and ARP. Param eters contained  in  the M D IF w ere those u tilised  b y  m ost 
authors who have investigated  m alaria  m ortality  in A frica and there w as a sim ilarity  in the 
observations. In v iew  o f  the inform ation it could provide i f  properly  used, the M D IF is a 
valid  tool for collecting data that the N M C P needs in o rder to  rationalise its strategies at 
U B H  and in other health  facilities. Its use should be generalised and com pulsory.
Introduction
More than 90% of worldwide malaria morbidity and 
mortality occurs in sub-Saharan Africa where about 
one million direct deaths are recorded annually. The 
fight against the pandemic is based on a long- term use 
o f highly efficacious treatment and transmission 
control (1,2). However, incomplete and imprecise case 
detection  and diagnosis im pede an accurate 
quantification of the disease burden (3,4).
In Zimbabwe, malaria is a serious public health 
problem with uneven geographical distribution and
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impact on local institutions and communities. For 
instance, no malaria, transmission has been reported in 
the two cities of Harare and Bulawayo that host the 
country's four tertiary level hospitals. However, 
conversely, the rate o f parasite resistance to available 
drugs in some rural areas (Chirundu, Hwange etc .. ) 
has put the country in the "action period" according to 
the WHO/AFRO classification (5 - 7).
The National Malaria Control Programme (NMCP) is 
a unit set up by the Ministry of Health for the control of 
the disease. It has produced and issued case 
m anagem ent guidelines and assigned specific
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objectives to health system facilities. In central 
hospitals, the intervention to be evaluated is malaria 
case management. This with other outcome indicators, 
especially the malaria case fatality rate (CFR), could 
then be used to assess the program implementation at 
those referral institutions. The M alaria Death 
Investigation. Form (MDIF) was introduced by the 
NMCP in the year 2000 for accurate identification o f 
management problems that impede the disease control 
nationally (5-7).
United Bulawayo Hospitals (UBH) is a group o f 
tertiary level hospitals. It receives referrals from the 
city and the southern part o f Zimbabwe, where many 
dry areas are infested by epidemic forms o f malaria, 
caused almost exclusively by Plasmodium Falciparum 
(PF)(5,6).
We found no publication on malaria deaths exploiting 
MDIF in Zimbabwe. In this study, the form was used to 
identify and document factors associated with malaria 
mortality at UBH and assess the validity and relevance 
o f information obtained in this way.
Materials and Methods
We reviewed the ward registers, infection control and 
prevention unit (ICP) weekly surveillance and monthly 
reports and medical records including MDIFs of 
patients admitted at UBH and whose cause o f death 
was malaria for the period 01 October 1996 to 30 
September 2000. We completed a MD IF for each 
patient without one. The MIDF is made o f 4 parts. The 
first part records patient's demographics and relevant 
past medical history (pregnancy and age, area visited, 
onset o f symptoms, self-treatment with chloroquine 
(CQ), malaria prophylaxis, concurrent illness). Each 
ofthe other 3 parts is to be filled at any health facility 
level for notification o f malaria death cases. They 
contain information on case management and follow 
up (means o f confirming the diagnosis, type and 
complications o f malaria, treatment details, date(s) and 
reasons o f referral to higher level health centre, 
duration o f illness, date and time of death and health 
provider's comments).
At UBH, specialists supervise in-patients care and 
ICP unit, experienced clerks man the information 
centre and wards are managed by Senior State 
Registered Nurses (SRNs). Malaria statistics are 
collected daily by the ICP sister-in-charge and 
dispatched weekly and monthly to relevant urban, 
provincial and national offices. As per WHO/PAHO 
and ICP national recommendations, malaria patients 
are reported by age group: 0-5 years, >5-15 years and 
>15 years and classified in 3 types: clinical (CLI), 
confirmed (CON) and cerebral malaria (CM) (8). CLI 
is a syndrome o f a pyrexial illness o f acute onset, 
occurring after visiting malaria infested area or not, 
accompanied by headache, joints pain and, especially 
in children, by other systemic manifestations. These 
may involve the respiratory (RS), cardiovascular
(CVS), central nervous (CNS) systems and the 
gastrointestinal tract (GIT). This syndrome, for which 
no other cause was found, responded well to 
antimalarial treatment though malaria parasite blood 
smear (MPS) was either negative or not done. CM was 
defined in clinical terms as presence o f  impaired level 
o f consciousness (LaC) due to malaria (3,8, 9); The 
level o f consciousness was assessed with the Glasgow 
Coma Scale (GCS). Complication such as respiratory 
distress (RD) was characterised by acidotic breathing 
and tachypnoea (rate> 24 per minute). Hypoglycaemia 
and anaemia were considered when blood glucose 
(RBS) was less than 2.2 mmol/L and haemoglobin
<6g%
Hyperpyrexia was a temperature > 39.5 DC. Only in­
patients with a confirmed diagnosis o f malaria at time 
of death were included in the study. Confirmation was 
defined as demonstration o f  PF or its antigens in blood 
or other tissues. These investigations could have been 
carried out in any health facility during the disease 
course that resulted in patient's death at UBH. Clinical 
or negative blood smear malaria cases were excluded.
Case management was evaluated using the guidelines 
for malaria diagnosis and treatment published by the 
Ministry o f Health and Child Welfare (10). Collection 
and analysis o f data was performed in and with 
Microsoft Excel. A sample o f MDIF is attached to this 
study.
Results
Malaria admissions, types and deaths From 01 
October 1996 to 30 September 2000, 2019 cases of 
suspected malaria were admitted at UBH o f which 
83(4.1 %) died. Those accounted for 2.2% o f overall 
admissions and 0.8% o f  deaths. All patients were 
managed in paediatric and medical wards. O f 470 
confirmed cases, 122 (26 %) occurred in the 0-5 years 
a g e  g ro u p , 40  (8 .5  % ) in  th e  5 -1 5 a n d  
308 (65.5 %) in the over 15. There were 53 (11.2%) 
deaths that were included in the study.
M DIF use
Only one (1.9%) MDIF was found filled in one 
patient record.
Dem ographics
O f 53 deaths, 16 (30.2%) were female including 
3 (1 8 .7 % ) p re g n a n t w o m en , g iv in g  a sex 
ratio M/F of2 .1:l. Forty-seven (88.6%) deaths 
occurred in the over 15 year age group. The 
under 5 and > 5-15  year age groups had 3 (5.7%) deaths 
e a c h .  T h e  a v e r a g e  a g e  w a s  3 3 . 6  
years (5 months - 74 years) and the median 35 (Q1 = 23 
and Q3 = 43) years.
Forty (75.4%) deaths occurred dining the rainy 
season (November - April), with a peak o f 15(28.3%) 
cases in April. The highest mortality rate was recorded 
in 1999 at 3.8 % while the lowest was in 1996 at 0.6 %. 
Fifty-two (98.1%) patients came from UBH urban and
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rural designated referring areas, namely 24 (46.0%) 
patients, including one each in the 0-5 and 5-15 age 
groups, from the city o f  Bulawayo and 28(54.0%) from 
the provinces (Matabeleland South: 24; Masvingo 
Province: 3 and Midlands: 1). One (1.9-%) patient 
came from Matabeleland North. Four patients, 2 in 
each o f the 0-5 and 5-15 years age group, came from 
rural area.
Past medical history.
Text box 1 gives information on the past medical 
history (PMH) o f the 53 malaria deaths. O f the dead, 
8(15%) Bulawayo residents reported no outside trip, 
85% visited rural areas, 87% sought treatment more 
than 24 hours after experiencing symptoms, and 53% 
did not take CQ before presenting to the health 
facility and 85% were referred more than 24 hours 
after complications had appeared.
Table I: Past medical history in UBHmalaria deaths, 
1996-2000 (n-53).
Drug Propylaxis data not available
Rural residence or visit in past 2-6 weeks: 45 (85%) 
Duration of symptoms (before seeking treatment:
- <24 hours
- >1-7 days
- >7 days
- Mean
25%
64%
11%
4.1 (0-14 days)
Chloroquine therapy before going to primary health facility:
Yes
No
Other
Time before referral to UBH:
- <24 hours 
-1 day
- 2 days
- >2 days
- Mean
21 cases, 20 (38%) 
completed course 
28 (53%) cases 
4 (8%) took oral quinine
8(15%)
25 (47%)
4(8%)
16(30%)
2.2 days (0 -14) days
Text box 2 provides information on malaria 
diagnosis and treatment in the study group at 
both referring and UBH levels.
Table II: Case management in malaria deaths at UBH, 1996-2000 (n-53).
Procedures Referring level results UBH Results
1. Investigations:
MPS taken Positive: 49 (92%) Positive: 33 (63%)
Missing: 4 (8%) Negative: 9 (17%)
Mean blood glucose level (n=4) NA*
Missing: 10 (19%)
Not done: 1 (2%) died before 
1.15 mmol/1 (0.5-1.8)
NA 4.9 g% (2.0 - 6.0)
Mean platelets counts (n=15) NA 48.9* 10A3 cells/mmA3 (18-121)
Mean urea (n=23) NA 36.21 mmol/1 (10-74)
Mean creatinine (n=19) NA 739 mmol/1 (135-2231)
LP (n=7) Not performed Positive: 1 (bacterial meningitis)
Electrolytes (Na, K) (n=6) NA
Normal: 5 
Missing: 1 
Normal
Chest X-ray (n=5) NA Abnormal: 5 (pneumonia)
HIV test (n=3) Not performed Positive: 3
Gastroscopy Not performed 1 (haematemesis)
Bone marrow aspiration Not performed 1 (severe anaemia)
2. Type of malaria diagnosed:
Severe/complicated 53 (100%) 53 (100%)
Cerebral malaria 23 (43%) 34 (64)
3. Treatment:
3.1 Antimalaria drugs given:
First line:
CQ 20 (completed oral CQ) 0
1 (incomplete course) 0
Oral Q 4 0
Oral SP 2 0
Second line: 
IV Q 26 (no loading dose) 52 (loading dose in 13)
IM Artemether 3 4 (from second day)
3.2 Atibiotics given according to EDLIZ (Penicillin, chloramphenicol, Gentamycin):
YesYes
3.3 Other drugs given according to EDLIZ:
Yes Yes
IV fluids (5% dextrose; 0.9%Nacl) 28 53
50% Dextrose NA 4
3.4 Other treatments given according to EDLIZ:
Peritoneal dialysis 0 4
Blood transfusion 0 2
*NA: data not available
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Diagnosis.
In all patients, malaria parasite slide (MPS) was taken 
and diagnosis o f complicated or severe malaria made 
at their primary health centres or by general 
practitioners. At UBH, MPS examination was 
performed in 52 (98.1 %) patients. One patient died 
before this procedure.
Reason for Referral and Admission.
All 53 (100%) cases were referred to or directly 
admitted at UBH for severe/complicated malaria. 
Among the reasons for referral, we found 25 (47.2%) 
cases o f CM, 23 (43.4%) cases o f deterioration of 
general condition, 11 (20.7%) cases o f convulsions, 3 
(5.7%) cases o f acute renal failure (ARF) and 1(1.9%) 
case each o f hyperpyrexia, acute gastro- enteritis, 
severe anaemia and bleeding tendency. All 3 children 
under 5 and 2 between 5 and 15 years had impaired 
LOC. In most cases, several complications were found 
in one single patient.
Referrals to UBH were decided by Medical Officers 
in 32 (62.0%) cases, by Clinical Officers in 3 (5.6%) 
cases, by SRNs in 12 (22,6%) cases and in 5 (9.4%) 
cases by State Certified Nurses (SCNs). Referral 
document was found in all referred cases.
Management at referring level.
Twenty-six (49%) patients including the 20 (37.7%) 
who had completed CQ course received parenteral 
Quinine (Q) as antimalarial second line drug in 
accordance with official guidelines, but without the 
loading dose. Time, route, doses and indications o f 
other drugs that were administered corresponded to 
official current recommendations. There were no 
data available for other investigations. Basic nursing 
care data were available and appropriate.
Management at UBH.
O f the 33 patients whose repeated slides were still 
positive at UBH, 20 (40%) had completed self- 
antimalarial treatment with CQ. As shown in Table 2, 
only few patients had basic laboratory investigations 
performed. Parasitaemia count was not done.
Monitored IV Q was commenced or continued in 52 
(98.1 %) patients o f  whom 13 (25.0%) had a loading 
dose. Intramuscular (IM) Artemether was injected 
from the second day o f  admission in 4 (7.6%) adult 
patients, including a woman who delivered a preterm 
baby. One patient died before any treatment could be 
instituted.
Antibiotics which were administered to patients 
fo llo w in g  o ff ic ia l rec o m m e n d a tio n s  w ere: 
oral (or per nasogastric tube) anti-tuberculous drugs in 
2 patients already on that treatment, IV Crystalline 
Penicillin plus IV Chloramphenicol in all cases o f 
suspected meningitis and pneumonia. IV Gentamycin 
was added in infant respiratory infections. Oral 
Cotrimoxazole was given against gastro-enteritis.
All patients were commenced or continued (for in­
patients referred from district hospitals) on TV fluids (5
% Dextrose, Ringer's Lactate, Normal Saline) 
especially for dehydration. Two (3.8%) patients were 
transfused. IV Frusemide and IV Diazepam were 
administered in acute renal failure (ARF) and fits 
respectively. IV 50% Dextrose (in bolus) was given in 
hypoglycaemia as were oxygen per mask and anti­
pyretics in respiratory distress (RD) and fever 
respectively. Peritoneal dialysis (PD) was initiated in 4 
(7.6%) cases o f ARF, gastroscopy and bone marrow 
aspiration (BMA) performed on one patient each. One 
o f seven lumbar punctures (LP) done for meningism 
show ed  acu te  b a c te r ia l  m e n in g itis  in  one 
child and 4 were normal.
In all cases, etiologic and symptomatic treatments 
were administered following official 
Recommendations.
Complications and associated conditions.
Apart from complicated/severe malaria that was 
diagnosed in all patients, the following conditions 
were also found present in 39 (73.5%) cases: 34 (64%) 
cases o f CM, 20 (37.7%) cases o f ARF, 14 (26.4%) 
cases o f bleeding tendency, 13 (24.5%) cases o f 
anaemia, 10 (18.8%) cases o f jaundice, 7 (13.2%) 
cases o f  RD, 5 (9.4%) cases o f pneumonia, 5(9.4%) 
cases o f gastro-enteritis and dehydration, 4 (7.6%) 
cases each  o f  h y p e rp y rex ia  and  shock , 2 
(3.7%) cases o f hypoglycaemia and 1 (1.9%) o f 
haemoglobinuria, 2 abortions and 1 preterm delivery.
Concurrent diseases often presented in combination 
i n  o n e  p a t i e n t .  H I V  / A I D S  w a s  
confirmed in 3(5.6%) patients. Meningitis was 
confirmed in one child. Five (9.4%) had pneumonia 
while 2(3.7%) were on antituberculous therapy. There 
were also 2(3.7%) cases o f septicaemia and one 
(1.8%) case each o f haemorrhagic colitis, diabetes 
mellitus and intestinal obstruction.
Hospital stays, post-mortem examination.
The mean stay was 2.7(0 - 10) days. Deaths were 
properly certified. Post-mortems (PM) was carried out 
in 3 (5.7%) patients. MPS were found in the brain, - 
co n firm in g  C M - in  2 (3 .7 % ) p a tie n ts  and 
haemorrhagic colitis found in one (1.9-%) case.
Discussion
As per NMCP recommendations, all cases were 
laborato ry  confirm ed. M aking th is accurate 
information on m alaria m ortality available is 
important since rational and targeted interventions and 
programme evaluation at UBH could then take place. 
Several authors . have emphasised the diagnostic 
aspect o f the disease because o f its economic, social 
and therapeutic implications. However, these figures 
from UBH could just represent the tip o f  the iceberg 
since, as shown in Textbox 1, the majority o f patients
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came from or visited the rural area which harbours 
most o f affected people. Furthermore, the similarities 
o f symptoms between malaria and other infections, 
m ultipathology and infraclinical parasitaem ia 
common in immune people in Africa are some o f the 
problems in estimating the malaria disease burden (1, 
3 ,11-14).
Unlike our findings, according to many authors, 
children are expected to suffer and die mostly from 
malaria. The implementation at lower levels o f the 
Integrated Management o f Child Illnesses (IMCI) and 
other child centred programmes may have contributed 
to that. However, adult morbidity and mortality 
figures were always higher than those o f children 
during presentations at Annual Malaria Meetings in 
Z i m b a b w e  i n  1 9 9 7 , 1 9 9 8 ,  1 9 9 9  a n d  
2000.
The MDIF was not used at UBH whereas tertiary 
level institutions have the most important role in 
malaria programme, namely case management. This 
would result in a lack o f feedback and evidence for 
programme managers and, therefore, ignorance o f 
specific issues in the treatment o f malaria. As stated in 
the methods, we filled in a MDIF for each patient 
included in the study in order to get uniformity o f the 
data we needed. We must, however, acknowledge the 
perfect concordance between wards, ICP and records 
unit documents. It allowed us to collect data from all 
confirmed cases o f malaria.
While the information obtained from the MDIFs on 
patients' demographics was quite sufficient, that on 
management at different levels depended on the 
quality o f the referral documents. Important data on 
the past medical history (PMH) including previous 
antimalarial treatment details, like dose, time and 
route, were not available.
Because o f the high risk of death due to malaria 
complications, the NMCP has established a strategy o f 
home-based and community prophylaxis and care 
such as Chloroquine holders in rural areas and drug 
availability over the counter at low price. Information 
on the disease is also given to the public through health 
education campaigns and materials. Those measures 
allow prevention and early treatment o f malaria in 
r u r a l  a r e a s  e s p e c i a l l y .  A n n u a l  
malaria workshops are held for health care workers to 
discuss issues on the disease (5- 7,10).
As shown in Text box 1, no information was 
available in patients' notes or referral letters 
concerning prophylaxis. The high proportion o f 
patients with a history of rural visits contrasts with that 
( lo w ) o f  th o se  w ho  fo llo w  th e  o f f ic ia l  
recommendations on malaria prevention and care. The 
delay in seeking treatment could indicate poor 
understanding o f health messages by the community 
or ignorance o f the potential rapid fatality o f malaria.
Decision o f referring patients to UBH was also taken 
late in general. A  similar attitude has been described in 
South Africa, Kenya and Tanzania (15-18).
The high risk o f abortion incurred by pregnant
women as well as the increase in prevalence recorded 
during the rainy season was also documented 
elsewhere. The city o f Bulawayo recorded 8 cases o f 
fatal malaria in patients with no history o f rural visit 
despite the assertion o f absence o f urban malaria 
transmission. Similar cases have been reported in 
other cities in Africa due to the degradation o f 
sanitation standards (2,3,13,18 - 24).
In all patients, no basic investigations except for 
MPS were carried out at referring level. That inability 
to accurately diagnose the complications coupled with 
the possible delay in transferring patients might have 
contributed in the global fatal outcome. This has also 
been reported by other authors (15-17).
Forty percent o f patients were found to be still 
positive for malaria at UBH despite completing CQ 
course self-treatment for 20 o f them prior to 
presenting to referring centres. The possibility o f CQ 
resistance should be ruled out in those cases. The 
eventuality o f this serious development has been 
reported already by several authors (7,12,23 - 28).
As in our study, Durrheim in South Africa like other 
authors also reported CM and ARF as the main causes 
o f death (15,18, 29, 30). Though post-mortem 
examination remains the ultimate tool for accurate 
diagnosis, it was carried out in 3 cases only. CM was 
confirmed in 2 patients and in the third, haemorrhagic 
colitis, thus implying the importance o f polypathology 
in our study.
Conclusion
Proper medical records keeping has made it possible 
to obtain accurate data on confirmed malaria deaths at 
UBH from 1996 - 2000. The causes o f death and other 
related parameters could be identified.
Most patients came late from rural area with 
complicated malaria and polypathology. Important 
information on malaria management prior and on 
admission to UBH was missing. Health education 
messages and existing guidelines on administration of 
Q in complicated cases before referral were not 
adhered to in many cases seen at health centres. 
General lack o f investigations including post-mortem 
examination might have resulted in delay in 
diagnosing, properly managing complications and 
establishing ultimate cause o f death.
Parameters presented on MDIF were also those 
taken into consideration by most authors who 
investigated malaria death in Africa. Our observations 
were globally similar to those found elsewhere. If  
properly used, the MDIF could be a valid and well- 
designed tool for collecting information on and 
adequately assessing management and cause of 
malaria mortality at all health system levels in the 
country.
Recommendations
The NMCP should regularly communicate with
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Central Hospitals to get first hand information on the 
implementation o f their recommendations.
The flaws found in the management of malaria at all 
levels must be channeled to the NMCP for further 
analysis and appropriate action to improve adherence 
to the established guidelines.
At UBH, the medical officer certifying the death o f a 
confirmed or suspected case of malaria must fill in the 
MDIF.
The heads o f the departments o f medicine and 
paediatrics must assign a focal person in their 
respective units who shall work with the ICP nurse 
regarding the collection o f relevant data on malaria.
The use o f the MD IF in its current format must be 
generalised and made compulsory in all private and
public institutions where malaria death can occur.
The malaria focal person o f the institution must train 
heath care workers locally in how to fill in the MDIF. 
The format and content could always be improved 
after stakeholders' meeting. The use o f computers in 
keeping MDIF information is safer and encouraged.
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MALARIA DEATH INVESTIGATION FORM
Name of Facility:.......................................................................................................................... District:...........................................................
Province:.......................................................................................................................................  Date Form Completed:....................................
Name of deceased:................................................................................................... Patient No:.........................  Age:...............................  Sex:.
Address (where resides):...................................................................................................................................................
Pregnant (Y/N) Estimated gestation (weeks):..................................................................................................................
Patient on drug prophylaxis (Y/N):..................................................................................  Which drugs:......................
Which areas did the visit in the past 2-6 weeks:..............................................................  Date of onset of symptoms.
Was chloroquine taken before presenting to the primary health facility (Y/N):..............  Date:..................................
Details of the patient’s visit to the health facility (PHC): 1" Level
Health facility name (PHC Level):.......................................................
Malaria slide taken (Y/N):..........................................  Result (-/+) N:,
Name of antimalaria drugs given:..............................  Dose:.............
Other drugs given:......................................................  Dose:.............
Date and time referred to the next level: 
Reasons for referral:..............................
Date and time patient presented:..............................
Type of malaria diagnosed (uncomplicated/Severe)
Route:......................................  Time given:.
Route:......................................  Time given:.
Details of the patient’s treatment at the second level referral centre: 2”" Level
Health facility name (PHC Level):............................................................................
Malaria slide taken (Y/N):..........................................  Result (-/+) N:
Name of antimalaria drugs given:..............................  Dose:.............
Other drugs given:......................................................  Dose:.............
Ancillary treatment (specify): Blood transfusion, glucose, other?
Date and time referred to the next level:........................................
Reasons for referral:........................................................................
Details of the patient’s treatment at the second level referral centre:
Health facility name (PHC Level):...........................................................
Malaria slide taken (Y/N):..........................................  Result (-/+) N:
Name of antimalaria drugs given:..............................  Dose:.............
Date and time patient presented:..............................
Type of malaria diagnosed (uncomplicated/Severe)
Route:......................................  Time given:.
Route:......................................  Time given:
Date and time patient presented:..............................
Type of malaria diagnosed (uncomplicated/Severe) 
Route:......................................  Time given:.........
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Other drugs given: Dose: Route: Time given:.
Tick all the complications observed at the health facility or listed in the documentation:
|  Cerebral malaria
■  Severe anaemia (Hb< or equal to 6g/dl) 
|  Jaundice
|  Severe haemoglobinuria 
H  Acute renal failure
■  Hypoglycaemia
■
■
■
■
■
■
Respiratory distress 
Bleeding tendencies 
Hyperpyrexia 
Shock
Hyperparasitaemia (>5% in non-immunes) 
Other (specify)
Duration of illness:................................................ Date of death:............... ...........  Time of death.......
Was any other concurrent illness present (Y/N):....
Health providers comments:.
Signed:. DMO/Mo/I/C:, Date:.
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